WOODSTOCK, United Kingdom, June 16 (Bernama-GLOBE NEWSWIRE) — Owen Mumford, a global leader in the design, manufacture and advancement of medical devices today announced that it has appointed Bal Johal as Director of Research and Development, effective from 4th July 2022.
Johal brings a wealth of experience in the pharmaceutical and medical device sector, covering a range of therapeutic areas and dosage forms, most recently working as vice president of product development, quality, regulatory and medical with Circassia. Prior to this, she held roles within research and development at GlaxoSmithKline, Pfizer and Mundipharma Research Ltd.